← Open Payments lookup

STEVEN SEGRAVES: Open Payments

NPI 1215916143 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,790 in 240 payments from 21 companies in 2025. Trend: 2023 $1,405 · 2024 $3,741 · 2025 $3,790

Food & beverage: $3,790
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.43$680
ABBVIE INC.37$533
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)32$434
Vanda Pharmaceuticals Inc.12$324
E.R. Squibb & Sons, L.L.C.23$265
Neurocrine BioSciences, Inc.14$238
Takeda Pharmaceuticals U.S.A., Inc.8$180
Lundbeck LLC8$169
Axsome Therapeutics, Inc.11$168
Collegium Pharmaceutical, Inc.17$160

Products named: REXULTI, VRAYLAR, CAPLYTA, HETLIOZ, COBENFY, INGREZZA, ABILIFY ASIMTUFII, TRINTELLIX.

Industry payments across KS — which companies pay providers there.